Open Beta
TREN
MetriLume
TREN

US marketsPAVM

SEC-sourced researchBeta

PAVM

PAVmed Inc.

Company comparison ↗

Data passport

CIK
0001624326
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Sep 10, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 2,995,000.0000 USD; December 2025: 71,000.0000 USD3M USD0 USD0December 2024December 2025
PAVM · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20242,995,000.0000Mar 27, 2026
December 202571,000.0000Mar 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202571,000.0000401,000.0000-5,206,000.000038,812,000.000016,512,000.0000Mar 27, 2026
December 20242,995,000.000039,791,000.0000-33,554,000.000030,660,000.000037,693,000.0000Mar 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$71KDecember 2025Mar 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$3MDecember 2024Mar 27, 202610-K
Net incomeNetIncomeLoss$401KDecember 2025Mar 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$5.21MDecember 2025Mar 27, 202610-K
Total assetsAssets$38.81MDecember 2025Mar 27, 202610-K
Total liabilitiesLiabilities$16.51MDecember 2025Mar 27, 202610-K

New filings

Explore methodology ↗